Abstract Bleomycin is a drug capable of inducing tissue fibrosis. In this study, the effects of bleomycin on gene expression of extracellular matrix encoding ·1(I) collagen, fibronectin and decorin were determined in vitro in human dermal fibroblasts. Northern blot analysis showed that bleomycin upregulated ·1(I) collagen, fibronectin and decorin gene expression dose-dependently between 1 nM and 1 μM. Bleomycin at 100 nM upregulated α1(I) collagen, fibronectin and decorin mRNA expression with a peak at 6 h following stimulation in normal skin fibroblast monolayers. Bleomycin enhanced mRNA expression encoding these extracellular matrix proteins in both normal dermal and scleroderma fibroblasts. Concomitant stimulation with bleomycin and interferon-γ (1000 U/ml), a representative antifibrotic cytokine, decreased ·1(I) collagen mRNA expression. Bleomycin also mildly upregulated mRNA expression of transforming growth factor-‚ (TGF-‚) and connective tissue growth factor (CTGF) coordinately in normal skin fibroblasts. Our results indicate that bleomycin modulates gene expression of extracellular matrix proteins in dermal fibroblasts, and this effect may be mediated by TGF-‚ and CTGF.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 20 April 2000 / Revised: 19 June 2000 / Accepted: 4 September 2000
Rights and permissions
About this article
Cite this article
Yamamoto, T., Eckes, B. & Krieg, T. Bleomycin increases steady-state levels of type I collagen, fibronectin and decorin mRNAs in human skin fibroblasts. Arch Dermatol Res 292, 556–561 (2000). https://doi.org/10.1007/s004030000180
Issue Date:
DOI: https://doi.org/10.1007/s004030000180